Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Schulz

Showing results (291-300 of 383) with videos related to

Pageof 39
Sort By:
Particle and Fibre Toxicology|March 17, 2011
The procoagulant effects of fine particulate matter in vivoEvren Kilinç, Holger Schulz, Gerhardus Jajm Kuiper, et al.
The Science of the Total Environment|November 2, 2020
Association of early life and acute pollen exposure with lung function and exhaled nitric oxide (FeNO). A prospective study up to adolescence in the GINIplus and LISA cohortKatrina A Lambert, Iana Markevych, Bo-Yi Yang, et al.
Neuro-Oncology|February 18, 2010
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphomaHendrik Pels, Annika Juergens, Isabell Schirgens, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in miceJames Y Lindsey, Koustav Ganguly, David M Brass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)Martin Sebastian, Andreas Gröschel, Sylvia Gütz, et al.
International Journal of Cancer|December 21, 2024
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registryMarc Thill, Mark-Oliver Zahn, Anja Welt, et al.
Metabolites|April 4, 2019
Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General PopulationBing Yu, Claudia Flexeder, Robert W McGarrah, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
Cancer Medicine|June 15, 2019
Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial: A thorough gender-specific analysis using the WoMo scoreMaria R Gaiser, Sylvie Lorenzen, Kirsten Merx, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2026
Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629)Ralf-Dieter Hofheinz, Ludwig Fischer von Weikersthal, Tobias Dechow, et al.
Pageof 39

Showing results (291-300 of 383) with videos related to

Sort By:
Pageof 39
Particle and Fibre Toxicology|March 17, 2011
The procoagulant effects of fine particulate matter in vivoEvren Kilinç, Holger Schulz, Gerhardus Jajm Kuiper, et al.
The Science of the Total Environment|November 2, 2020
Association of early life and acute pollen exposure with lung function and exhaled nitric oxide (FeNO). A prospective study up to adolescence in the GINIplus and LISA cohortKatrina A Lambert, Iana Markevych, Bo-Yi Yang, et al.
Neuro-Oncology|February 18, 2010
Early complete response during chemotherapy predicts favorable outcome in patients with primary CNS lymphomaHendrik Pels, Annika Juergens, Isabell Schirgens, et al.
American Journal of Respiratory and Critical Care Medicine|April 8, 2011
c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in miceJames Y Lindsey, Koustav Ganguly, David M Brass, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2021
Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)Martin Sebastian, Andreas Gröschel, Sylvia Gütz, et al.
International Journal of Cancer|December 21, 2024
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registryMarc Thill, Mark-Oliver Zahn, Anja Welt, et al.
Metabolites|April 4, 2019
Metabolomics Identifies Novel Blood Biomarkers of Pulmonary Function and COPD in the General PopulationBing Yu, Claudia Flexeder, Robert W McGarrah, et al.
Leukemia & Lymphoma|December 10, 2024
Treatment adherence and effectiveness in patients treated with carfilzomib-based therapy combinations for relapsed/refractory multiple myeloma in Germany: interim results from the non-interventional CARO studyWolfgang Knauf, Jens Uhlig, Eyck von der Heyde, et al.
Cancer Medicine|June 15, 2019
Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial: A thorough gender-specific analysis using the WoMo scoreMaria R Gaiser, Sylvie Lorenzen, Kirsten Merx, et al.
European Journal of Cancer (Oxford, England : 1990)|March 29, 2026
Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer - The randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629)Ralf-Dieter Hofheinz, Ludwig Fischer von Weikersthal, Tobias Dechow, et al.
Pageof 39